Health
Nigeria declares war against yellow fever, set to vaccinate 25million people
|
The Government of Nigeria is billed to launch a mass vaccination campaign to prevent the spread of yellow fever on Thursday with support from the World Health Organization, WHO and partners. More than 25 million people will be vaccinated throughout 2018, in the largest yellow fever vaccination drive in the country’s history.
The immunization plan is part of efforts to eliminate yellow fever epidemics globally by 2026. The preventive campaign will use vaccines funded by Gavi, the Vaccine Alliance, and will be supported by UNICEF. It will begin on 25 January in Kogi, Kwara and Zamfara states, and then move to Borno state where the campaign will focus on camps for internally displaced persons and surrounding host communities. More than 8.6 million people will be vaccinated in the four states in the coming days. “The goal of the Yellow Fever Preventive Mass Vaccination Campaign is to reduce yellow fever transmission by achieving 90% coverage in implementing States and Local Government Areas in line with the strategy for the Elimination of Yellow fever Epidemics by 2026,” said Dr Faisal Shuaib, Executive Director of National Primary Healthcare Development Agency. Yellow fever is a vaccine-preventable acute viral haemorrhagic disease transmitted by infected mosquitoes. The current yellow fever outbreak in Nigeria began in Ifelodun, Kwara State in western Nigeria in September 2017. By early January 2018, a total of 358 suspected cases had been reported in 16 states, with 45 deaths. In late 2017, Nigeria vaccinated more than three million people in an initial emergency yellow fever vaccination campaign with the aim of quickly containing the outbreak. However, the yellow fever virus continues to circulate in different parts of the country where people remain largely unprotected. WHO is supporting the vaccine drive by training thousands of healthcare workers on how to administer the vaccine, helping to track cases of yellow fever and providing coordination and logistical support for this highly complex operation. “With a single dose of vaccine, an individual is protected for life against yellow fever,” said Dr Wondimagegnehu Alemu, WHO Representative in Nigeria. “This is a massive undertaking which took weeks of planning. Nearly 3000 vaccination teams are being deployed across the four states participating in the campaign.” EYE: setting sights for 2026 A coalition of partners developed the Eliminate Yellow fever Epidemics (EYE) Strategy, steered by WHO, Gavi and UNICEF, to protect at-risk populations, prevent international spread and contain outbreaks rapidly. As a zoonosis (any disease or infection that is naturally transmissible from vertebrate animals to humans), yellow fever cannot be eradicated, but epidemics can be eliminated if population immunity levels are effectively raised through mass vaccination and sustained by routine infant immunization. The EYE Strategy’s goal is to eliminate yellow fever epidemics globally by 2026. A second phase of the mass vaccination campaign in Nigeria is expected to occur later in 2018. This is part of a phased approach to build immunity among residents. “This should provide high population immunity nationwide. WHO calls for partners’ continued support to protect the Nigerian people and end yellow fever epidemics by 2026,” Dr Alemu said |
The West African Society of Parenteral & Enteral Nutrition (WASPEN) has called on President Bola Ahmed Tinubu to make clinical malnutrition a national healthcare priority, warning that the crisis is growing but remains largely overlooked in Nigeria’s healthcare system.
WASPEN’s Founder and President, Dr. Teresa Pounds, made this appeal on Monday during a press conference ahead of the 2025 WASPEN Clinical Nutrition Conference, scheduled for June 17–19 in collaboration with the National Hospital Abuja.
Themed “Bridging the Gap: Integrating Hospital and Community Malnutrition Care in Developing Countries,” the event aims to foster solutions for hospital and community malnutrition.
Describing malnutrition as “the skeleton in the hospital’s closet,” Dr. Pounds emphasised the need for urgent awareness, policy reform, and collaboration among healthcare stakeholders to ensure effective hospital nutrition programs.
“Many patients in Nigerian hospitals suffer from inadequate nutritional support, leading to prolonged hospital stays, increased complications, and higher mortality rates. This issue must be addressed at the highest level,” she stated.
The press conference was attended by the management of Genrith Pharmaceuticals Limited, a major partner, led by its CEO, Chief Emmanuel Umenwa.
Call for National Clinical Nutrition Policy
Dr. Pounds, a U.S.-based specialist in critical care nutrition and a board-certified nutrition support pharmacist, urged the government to implement a national policy framework to support specialised clinical nutrition interventions. She stressed the importance of integrating mandatory nutrition screening and intervention into all healthcare facilities.
She also called on the Federal and State Ministries of Health to expand and enforce standardised clinical nutrition policies, ensure hospitals conduct structured nutrition screening for all patients, makes medical nutrition therapy accessible and affordable, and support research and local production of specialised nutritional products.
She further encouraged NAFDAC, NIPRD, pharmaceutical companies, and NGOs to collaborate on research, funding, and product development to improve hospital and community-based nutritional care.
Invest in Africa’s food markets to win the war on hunger, boost nutrition – AfDB
“We need a national framework that ensures no patient suffers due to a lack of proper nutrition,” the expert stressed.
Conference to Attract Top Medical and Policy Experts
Speaking on the upcoming conference, Dr. Pounds noted that it will bring together leading medical experts, policymakers, and healthcare stakeholders to develop strategies for addressing malnutrition.
Prominent figures expected at the event include Prof. Ali Pate, Coordinating Minister of Health (Special Guest of Honour), Nyesom Wike, Minister of the FCT (Chief Host), Prof. Muhammad Raji Mahmud, Chief Medical Director, National Hospital Abuja (Host), Prof. Audu Bala, President, Nigerian Medical Association (Keynote Speaker), Pharm. Ibrahim Tanko Ayuba, President, Pharmaceutical Society of Nigeria (Guest of Honour), and Prof. Salisu Maiwada Abubaka, President, Nutrition Society of Nigeria (Guest of Honour) admiration.
Pre-Conference Activities
Prof. Raji Mahmud, Chief Medical Director of the National Hospital Abuja, represented by the Chairperson of the Local Organising Committee (LOC), Pharm. Adesola Clara assured that the hospital has the necessary facilities and expertise to host a successful conference. He emphasised that the hospital is fully prepared for the programme.
Also, the WASPEN Central Planning Committee, led by Mrs. Ghinsel Blessing, revealed that pre-conference activities will include a hands-on training workshop on nutritional kits in hospitals, scheduled for June 16, a health walk to raise awareness about hospital malnutrition, expected to be led by First Lady Sen. Oluremi Tinubu.
With malnutrition posing a silent but deadly threat to healthcare outcomes, WASPEN hopes that the Tinubu administration will take decisive action to integrate nutrition-focused interventions into Nigeria’s health policies.
The 2025 WASPEN Clinical Nutrition Conference is expected to be a game-changer in shaping the future of clinical nutrition in Nigeria and West Africa.
Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.
United Therapeutics along with another company, eGenesis, have been working since 2021 on experiments implanting pig kidneys into humans: initially brain-dead patients and more recently living recipients.
Advocates hope the approach will help address the severe organ shortage. More than 100,000 people in the United States are awaiting transplants, including over 90,000 in need of kidneys.
United Therapeutics’s approval, announced Monday, allows the company to advance its technology toward a licensed product if the trial succeeds.
The study authorization was hailed as a “significant step forward in our relentless mission to expand the availability of transplantable organs,” by Leigh Peterson, the company’s executive vice president.
The trial will initially enroll six patients with the end-stage renal disease before expanding to as many as 50, United Therapeutics said in a statement. The first transplant is expected in mid-2025.
Meanwhile, rival eGenesis said it had received FDA approval in December for a separate three-patient kidney study.
“The study will evaluate patients with kidney failure who are listed for a transplant but who face a low probability of receiving a deceased donor offer within a five-year timeframe,” the company said.
Xenotransplantation — transplanting organs from one species to another — has been a tantalizing yet elusive goal for science.
Early experiments in primates faltered, but advances in gene editing and immune system management have brought the field closer to reality.
Pigs have emerged as ideal donors: they grow quickly, produce large litters, and are already part of the human food supply.
United Therapeutics said trial patients would be monitored for life, assessing survival rates, kidney function, and the risk of zoonotic infections — diseases that jump from animals to humans.
Currently, there is only one living human recipient of a pig organ: Towana Looney, a 53-year-old from Alabama who received a United Therapeutics kidney on November 25, 2024.
She is also the longest-surviving recipient, having lived with a pig kidney for 71 days as of Tuesday. David Bennett of Maryland received a pig heart in 2022 and survived 60 days.
The Swiss government said Thursday it aimed to overhaul its law on medically-assisted reproduction to legalise egg donations and give broader access to sperm donations.
Currently egg donations are not allowed and only married couples can access sperm donations.
The Swiss parliament has long said it wants to change that, and has asked the government with coming up with a proposal to provide broader access.
A government statement said it had “decided to completely revise the law on medically assisted reproduction in order to adapt it to the current context” and had asked the interior ministry to draft a proposed law by the end of next year.
The government said it wants to legalise egg donations in cases where a woman in a couple is infertile, as a parallel to the already legal use of sperm donations in cases of male sterility.
Bern said its priority was “the protection of donors and the welfare of the child”, stressing that “this protection cannot be guaranteed if parents resort to egg donation abroad”.
The government also said it wanted to expand access to both egg and sperm donation to unmarried couples.
After Switzerland legalised same-sex marriage in 2022, married lesbian couples have also had access to sperm donations.
But the government said the current law barring unmarried couples from access to such medically assisted reproduction was “outdated and no longer corresponds to social reality”.
-
News3 days agoAlleged KGB Infiltration: Police in Dilemma as Senator Natasha Abandons Petition, Snubs Summons
-
News1 week ago
Rivers Sole Administrator Announces Release of Withheld Allocations
-
Politics1 week ago
2027 Presidency: Obi Yet to Declare Intentions as Loyalists Engage SDP
-
News2 days ago
Rep. Oseni Condoles Late Gov. Ajimobi, Kola-Daisi Families Over Bisola’s Passing
